This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Other Status Epilepticus

Contents — quick navigation
ABasic informationICD-10: G41.8 | Special Copayment Reduction: V125 | Coverage period: 5 years
BSynonymsOther types of SE; includes tonic SE, myoclonic SE, subtle SE, electrographic-only SE, etc.
CAdult onsetMyoclonic SE: common in patients with severe brain injury (after cardiac arrest). Tonic SE: may occur in adult patients with LGS
S1HistoryChanging recognition of atypical types in the history of SE classification
S2CausesVaries by SE type; brain injury, LGS, metabolic abnormalities, severe hypoxic encephalopathy
S3GeneticsMyoclonic SE: SCN1A, POLG; tonic SE: LGS-related genes
S4General epidemiologyOther types of SE are about 5–15% of all SE; a considerable proportion in intensive care units
S5PathophysiologyType-specific pathophysiology; common failure of seizure termination mechanisms
S6SymptomsClinical features by type: sustained tonic posturing, continuous myoclonus, loss of consciousness with subtle convulsions
S7SignsEEG and clinical signs by type; key role of cEEG monitoring
S8ScreeningcEEG monitoring in the intensive care unit; screening for the underlying disease
S9DiagnosisDiagnosis by type classification; application of ILAE 2015 criteria
S10TreatmentTreatment by type; therapeutic limitations in myoclonic SE (posthypoxic)
S11PrognosisVaries by type; posthypoxic myoclonic SE is extremely poor
S12PreventionBrain-protective treatment after cardiac arrest; optimal management of LGS; intensive monitoring
S13References10 key references

S1. History

In the history of status epilepticus (SE) classification, systematic recognition of "other" types besides tonic-clonic SE and absence SE came relatively late. Interest in the diversity of SE grew from the 1960s, but atypical types were dealt with mainly at the level of case reports.

Tonic SE was observed mainly in patients with LGS and became known as "tonic SE in LGS." In 1966, Gastaut and colleagues described a continuous state of repetitive tonic seizures occurring during sleep. Myoclonic SE appears in various contexts, and in particular the fact that myoclonic SE occurring in hypoxic encephalopathy after cardiac arrest (distinguished from Lance-Adams syndrome) is associated with a poor prognosis was recognized in the 1970s–80s.

Subtle SE drew attention when Treiman et al. (1984) described a state in which convulsive SE fails to respond to treatment and the clinical manifestations of convulsions gradually diminish while seizures persist on EEG. Later, with the introduction of continuous EEG (cEEG) monitoring in ICU patients, various types of SE that had not been clinically recognized began to be discovered. The 2015 ILAE SE classification systematically organized these various types, integrating classification by the presence or absence of motor symptoms with classification by EEG pattern.

Recently, EEG-based concepts such as "electrographic SE only" and "prolonged epileptiform discharges" have become clinically important, and standardization of cEEG monitoring in the ICU setting is underway.

S2. Causes

Other SE (G41.8) encompasses several clinical types, and the main causes differ by type.

Tonic SE

Myoclonic SE

Subtle SE

Simple Partial SE / Focal Motor SE

S3. Genetics

The main genetic causes related to other SE types are as follows.

Genes related to myoclonic SE

Genes related to tonic SE

Genes associated with LGS (TSC1/2, CDKL5, ARX, etc.) form the genetic background of tonic SE. Genetic testing is used to identify the cause of the underlying LGS or developmental epileptic encephalopathy.

Rasmussen encephalitis

Rasmussen encephalitis is not a hereditary disease; it arises by an autoimmune mechanism (GluA3 receptor antibodies, mediated by cytotoxic T lymphocytes). Epilepsia partialis continua is characteristic.

S4. General epidemiology

Epidemiological data combining the other SE types are limited, but the proportion of all SE patients accounted for by these types is estimated at about 5–15%.

Tonic SE

The lifetime incidence of tonic SE in patients with LGS is quite high (estimated at 20–40%). In particular, it often occurs during sleep and is sometimes not clinically recognized.

Myoclonic SE

The incidence of myoclonic SE in patients with hypoxic encephalopathy after cardiac arrest is about 10–40%. When cEEG monitoring is performed in ICU patients, the proportion of electrographic seizures that are not clinically recognized reaches 8–34%.

Epilepsia Partialis Continua

Epilepsia partialis continua (EPC) is estimated to be a rare condition occurring in fewer than 1 per 100,000 people. Rasmussen encephalitis, malformations of cortical development, stroke, and others are the main causes.

S5. Pathophysiology

Mechanism of tonic SE

In LGS, tonic SE is associated with the continuous occurrence of generalized paroxysmal fast activity (GPFA, ≥10 Hz) during sleep. A hyperexcitable state of brainstem-cortical pathways continuously activates the motor output that produces tonic posturing. The paradoxical effect of benzodiazepines (worsening of tonic seizures) observed in some LGS patients suggests the complexity of this mechanism.

Mechanism of posthypoxic myoclonic SE

Widespread cortical injury after cardiac arrest induces synchronized myoclonic discharges in cortical and subcortical structures. Cortical disinhibition is the key mechanism of myoclonic SE, caused by the loss of GABAergic inhibition. Distinguishing cortical myoclonus from myoclonus of subcortical origin is important for determining prognosis.

Mechanism of subtle SE

In prolonged convulsive SE, progressive internalization of GABA-A receptors reduces clinical convulsions while EEG seizure discharges persist. In this state, the brain is exposed to ongoing excitotoxic injury, which affects neurological outcome.

Epilepsia partialis continua (EPC)

An excitation-inhibition imbalance around focal cortical lesions causes persistent focal seizure discharges. In Rasmussen encephalitis, cortical cell loss caused by cytotoxic T lymphocytes leads to progressively increasing excitability.

S6. Symptoms

SE typeClinical featuresLevel of consciousness
Tonic SEContinuous or repetitive generalized stiffening; limb extension; apnea possible; frequent during sleepLost or severely clouded
Myoclonic SE (posthypoxic)Continuous myoclonus of the face and limbs; occurs after cardiac arrest; unconsciousComa
Myoclonic SE (other)Repetitive myoclonus of the limbs and trunk; rhythmic or irregularVariable
Subtle SESubtle eye deviation, eyelid twitching, subtle twitching of fingers/toes; occurs after convulsive SEComa or severe clouding
Epilepsia partialis continuaContinuous focal clonic jerking of part of the body (hours to days); consciousness may be preservedGenerally preserved
Electrographic-only SENo clinical signs; confirmed only by EEGComa (ICU patients)

S7. Signs

Key role of continuous EEG (cEEG) monitoring

In other SE types, diagnosis based on clinical signs alone is often impossible or very difficult. In the intensive care unit, cEEG monitoring is essential for detecting subtle SE, electrographic-only SE, burst-suppression patterns, and so on. The American Clinical Neurophysiology Society (ACNS) recommends cEEG monitoring in specific patient groups in the intensive care unit (coma, intracerebral hemorrhage, history of epilepsy, post–cardiac arrest, etc.).

EEG findings by type

Clinical signs

In posthypoxic myoclonic SE, asynchronous or synchronous myoclonus of the face (eyelids, perioral region) and limbs is observed. In epilepsia partialis continua, continuous rhythmic jerking is observed in part of the body (thumb, one side of the face, etc.), and consciousness is preserved.

S8. Screening

cEEG monitoring in the intensive care unit

According to ACNS guidelines, cEEG monitoring is recommended in the following patient groups.

Screening for the underlying disease

Depending on the provoking cause, blood tests (lactate, amino acids, organic acids), electromyography (to distinguish cortical from subcortical myoclonus), and neuroimaging (brain MRI, especially DWI) are needed. When POLG-related myoclonic SE is suspected, genetic testing and liver function tests are performed.

S9. Diagnosis

Diagnosis of other SE is made by integrating motor type, level of consciousness, and EEG findings according to the ILAE 2015 SE classification criteria.

Diagnostic criteria by type

TypeDiagnostic criteria
Tonic SEContinuous/repetitive tonic seizures ≥5 minutes; generalized GPFA on EEG; underlying history of LGS
Myoclonic SEContinuous myoclonic discharges; EEG correlate of cortical origin; causal context (hypoxia, LGS, JME, etc.)
Epilepsia partialis continuaFocal clonic jerking ≥1 hour; consciousness preserved; focal cortical EEG discharges
Subtle SEMinimal clinical convulsions after convulsive SE; persistent seizures on EEG; no recovery of consciousness
Electrographic-only SENo clinical symptoms; seizure discharges confirmed only by cEEG; ICU patients

Application of the Salzburg criteria

Among nonconvulsive SE types, the Salzburg criteria are useful for diagnosing electrographic-only SE. However, the clinical significance of seizure discharges within a burst-suppression pattern and the need to treat them are still debated.

S10. Treatment

Tonic SE

Myoclonic SE

Epilepsia partialis continua (EPC)

Treatment of nonconvulsive SE in the intensive care unit

In electrographic-only SE, the aggressiveness of treatment is decided according to the clinical context. Aggressive antiseizure treatment is recommended in patients with potential for recovery from brain injury, but treatment decisions in patients with irreversible severe brain injury involve ethical judgment.

S11. Prognosis

SE typePrognosis
Tonic SE (LGS)Follows the underlying prognosis of LGS; short-term mortality from SE itself is low, but repeated episodes cause functional decline
Posthypoxic myoclonic SEExtremely poor; most die or remain in a vegetative state; some survive with Lance-Adams syndrome
Epilepsia partialis continuaVaries by underlying disease; Rasmussen encephalitis worsens progressively; other causes relatively favorable
Subtle SEPoor; dependent on the severity of underlying brain injury; good outcome in fewer than 30%
Electrographic-only SEIndependent effect unclear; associated with the prognosis of the underlying disease

In posthypoxic myoclonic SE, a burst-suppression pattern on EEG is an indicator of extremely poor prognosis and is used together with other indicators (somatosensory evoked potentials, NSE, neuroimaging) in neurological prognostication.

S12. Prevention

S13. References

  1. Trinka E, et al. A definition and classification of status epilepticus. Epilepsia. 2015;56(10):1515-1523. PMID: 26336950.
  2. Rossetti AO, et al. Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia. Neurology. 2009;72(8):744-749. PMID: 19237706.
  3. Hirsch LJ, et al. Practice guideline: Disorders of consciousness — Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;91:450-460.
  4. Treiman DM. Electroclinical features of status epilepticus. J Clin Neurophysiol. 1995;12(4):343-362. PMID: 7560012.
  5. Wheless JW, et al. Lennox-Gastaut syndrome: treatment and management. Epileptic Disord. 2014;16(S1):S39-S62.
  6. Bien CG, et al. Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins. Epilepsia. 2013;54(3):543-550. PMID: 23294038.
  7. Rossetti AO, et al. Status epilepticus: an independent outcome predictor after cerebral anoxia. Neurology. 2010;75(17):1515-1519. PMID: 20975058.
  8. Herman ST, et al. Consensus statement on continuous EEG in critically ill adults and children, part I. J Clin Neurophysiol. 2015;32(2):87-95. PMID: 25626778.
  9. Claassen J, et al. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62(10):1743-1748. PMID: 15159471.
  10. Hocker S. Systemic complications of status epilepticus — an update. Epilepsy Behav. 2015;49:83-87. PMID: 25890264.